Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;17(3):567-595.
doi: 10.1038/s41596-021-00649-4. Epub 2022 Feb 4.

A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus

Hamed Ekhtiari  1   2 Mehran Zare-Bidoky #  3   4 Arshiya Sangchooli #  3 Amy C Janes  5 Marc J Kaufman  5 Jason A Oliver  6   7   8 James J Prisciandaro  9 Torsten Wüstenberg  10 Raymond F Anton  9 Patrick Bach  11 Alex Baldacchino  12 Anne Beck  10   13 James M Bjork  14 Judson Brewer  15 Anna Rose Childress  16 Eric D Claus  17 Kelly E Courtney  18 Mohsen Ebrahimi  3 Francesca M Filbey  19 Dara G Ghahremani  20 Peyman Ghobadi Azbari  3   21 Rita Z Goldstein  22 Anna E Goudriaan  23 Erica N Grodin  20 J Paul Hamilton  24   25 Colleen A Hanlon  26 Peyman Hassani-Abharian  27 Andreas Heinz  10 Jane E Joseph  28 Falk Kiefer  11 Arash Khojasteh Zonoozi  3   29 Hedy Kober  30 Rayus Kuplicki  31 Qiang Li  32 Edythe D London  20 Joseph McClernon  6 Hamid R Noori  33   34 Max M Owens  35 Martin P Paulus  31 Irene Perini  24   25 Marc Potenza  30   36   37   38 Stéphane Potvin  39 Lara Ray  20 Joseph P Schacht  40 Dongju Seo  30 Rajita Sinha  30 Michael N Smolka  41 Rainer Spanagel  42 Vaughn R Steele  30 Elliot A Stein  43 Sabine Steins-Loeber  44 Susan F Tapert  18 Antonio Verdejo-Garcia  45 Sabine Vollstädt-Klein  11 Reagan R Wetherill  16 Stephen J Wilson  46 Katie Witkiewitz  47 Kai Yuan  48 Xiaochu Zhang  49   50 Anna Zilverstand  51
Affiliations

A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus

Hamed Ekhtiari et al. Nat Protoc. 2022 Mar.

Abstract

Cue reactivity is one of the most frequently used paradigms in functional magnetic resonance imaging (fMRI) studies of substance use disorders (SUDs). Although there have been promising results elucidating the neurocognitive mechanisms of SUDs and SUD treatments, the interpretability and reproducibility of these studies is limited by incomplete reporting of participants' characteristics, task design, craving assessment, scanning preparation and analysis decisions in fMRI drug cue reactivity (FDCR) experiments. This hampers clinical translation, not least because systematic review and meta-analysis of published work are difficult. This consensus paper and Delphi study aims to outline the important methodological aspects of FDCR research, present structured recommendations for more comprehensive methods reporting and review the FDCR literature to assess the reporting of items that are deemed important. Forty-five FDCR scientists from around the world participated in this study. First, an initial checklist of items deemed important in FDCR studies was developed by several members of the Enhanced NeuroImaging Genetics through Meta-Analyses (ENIGMA) Addiction working group on the basis of a systematic review. Using a modified Delphi consensus method, all experts were asked to comment on, revise or add items to the initial checklist, and then to rate the importance of each item in subsequent rounds. The reporting status of the items in the final checklist was investigated in 108 recently published FDCR studies identified through a systematic review. By the final round, 38 items reached the consensus threshold and were classified under seven major categories: 'Participants' Characteristics', 'General fMRI Information', 'General Task Information', 'Cue Information', 'Craving Assessment Inside Scanner', 'Craving Assessment Outside Scanner' and 'Pre- and Post-Scanning Considerations'. The review of the 108 FDCR papers revealed significant gaps in the reporting of the items considered important by the experts. For instance, whereas items in the 'General fMRI Information' category were reported in 90.5% of the reviewed papers, items in the 'Pre- and Post-Scanning Considerations' category were reported by only 44.7% of reviewed FDCR studies. Considering the notable and sometimes unexpected gaps in the reporting of items deemed to be important by experts in any FDCR study, the protocols could benefit from the adoption of reporting standards. This checklist, a living document to be updated as the field and its methods advance, can help improve experimental design, reporting and the widespread understanding of the FDCR protocols. This checklist can also provide a sample for developing consensus statements for protocols in other areas of task-based fMRI.

PubMed Disclaimer

Figures

Extended Data Fig. 1 |
Extended Data Fig. 1 |. Inter-rater reliability for individual checklist items.
Inter-rater reliability assessed by Fleiss’ Kappa for each ENIGMA ACRI checklist item, calculated on the basis of the assessment of reporting status of the checklist items among 108 papers by three independent raters.
Extended Data Fig. 2 |
Extended Data Fig. 2 |. Relationships between reporting score and publication context.
a, Relation between the reporting score of each article and its word count. (Note that article word count is not exactly accurate, because it is measured by counting the words from the beginning of the introduction to the end of the discussion; thus, it might include the running title of each page, footnotes and the captions of figures and tables.) b, Relation between the reporting score of each article and its journal word limit. (Note that the word limitation for journals with no word limitation is counted as 15,000.) c, Relation between the reporting score of each article with journal impact factor. d, Article reporting scores across the years. The relations in panels a, b and c were assessed using linear regressions, whereas a Kruskal-Wallis test was performed for panel d.
Fig. 1 |
Fig. 1 |. Schematic representation of key reportable aspects of an fMRI drug cue reactivity study.
1. Participants are recruited on the basis of explicit criteria, and baseline data are collected on participant demographics, handedness, psychiatric history and substance use history. 2. Participants undergo fMRI scanning with carefully selected hardware and software parameters, and data are analyzed through specified preprocessing and analysis pipelines for statistical inference. 3. Participants engage with drug and neutral cues during fMRI scanning, with cues of specified durations presented in events and/or blocks with a chosen temporal architecture. 4. These cues stimulate one or more sensory modalities and are typically matched in terms of psychological characteristics, such as induced arousal or valence, and/or physical characteristics, such as saturation and hue for pictorial cues. 5. and 6. Participants provide craving self-reports outside and/or inside the scanner, using various short and long-form instruments and hardware such as response boxes or joysticks. 7. In addition to pre-scanning sources of between-study variance such as task instructions and scanner familiarization, there are important post-scanning safety procedures such as craving-management interventions and additional assessments before participants leave the imaging center.
Fig. 2 |
Fig. 2 |. A schematic of the entire Delphi study methodology.
The process has been roughly divided into distinct stages: the selection of the SC (in black) using the results of an earlier mentioned systematic review to choose the initial checklist items and expert committee candidates (in pink), checklist development phase (in red), expert panel selection (in purple), checklist commenting and revision phase (in green), checklist rating phase (in yellow) and data analysis and Delphi process finalization (in blue). The number of contributors to each section is displayed by ‘n =‘. To the left of the main graph, an overview of the structure of the checklist at each stage is presented. recom, recommendations.
Fig. 3 |
Fig. 3 |. Ratings for 38 items in seven categories.
This figure depicts the rating of 49 raters (11 from the steering committee and 38 from the expert panel) for the checklist items. Each item was rated from 1 to 5 (not important to extremely important). All the items met threshold 1 and were rated as moderately, highly or extremely important by >70% of the raters. In addition, 24 items reached the more-stringent threshold 2 of being rated as either highly or extremely important by 80% of raters (the ones that did not reach this threshold are marked with ‘†’). Items are represented by their summary in the figure. Full text of the items is provided in Tables 1–6.
Fig. 4 |
Fig. 4 |. Ratings for 75 additional recommendations in seven categories.
This figure depicts the rating of 49 raters (11 from the steering committee and 38 from the expert panel) for the checklist additional recommendations. Each additional recommendation was rated either ‘Yes’ or ‘No’ on the question of whether it should be included as a recommendation. Recommendations are represented by their summary in the figure. Full text of the recommendations is provided in Tables 1–6.
Fig. 5 |
Fig. 5 |. State of reproducibility/transparency in fMRI drug cue reactivity research in the context of the ENIGMA-ACRI checklist.
Assessments by three independent raters on the basis of 108 FDCR articles. a, Percentage of articles that reported each checklist item. Note that the percentages are calculated out of applicable items for each article. For example, craving-rating technology was not applicable for an article without craving rating. b, Percentage of overall reporting status of articles.

References

    1. Degenhardt L. et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry 5, 987–1012 (2018). - PMC - PubMed
    1. Ekhtiari H. et al. Functional neuroimaging for addiction medicine: from mechanisms to practical considerations. Prog. Brain Res 224, 129–153 (2016). - PubMed
    1. Moeller SJ & Paulus MP Toward biomarkers of the addicted human brain: using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 80, 143–154 (2018). - PMC - PubMed
    1. Ekhtiari H. et al. Neuroscience of drug craving for addiction medicine: from circuits to therapies. Prog. Brain Res 223, 115–141 (2016). - PubMed
    1. Ekhtiari H. & ACRI Secretariat. A systematic review on fMRI drug cue reactivity studies (OSF, 2020). https://osf.io/eb972/(2020).

Publication types

Grants and funding